Rank #1297LNTH

Lantheus Holdings, Inc.

$73.18

0.16% (Daily)

Market Cap

$4.98B

Revenue

$1.53B

Rank by MCap

#1297

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Robert J. Marshall Jr., CFA

Headquarters

Bedford, MA

Employees

808

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area...